Inventor · disambiguated record
Julien Auguste Germain Boudet
Also filed as: BOUDET JULIEN AUGUSTE GERMAIN
5 granted patents·5 pending applications·25 citations·filing 2017–2025
76Inventor score
Top patents by PatentIndex Score
10 records- 0193US11851656B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2021·Granted Dec 26, 2023·6 cites·40 claims
- 0293US10941402B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2017·Granted Mar 9, 2021·16 cites·22 claims
- 0391US12203072B2Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2023·Granted Jan 21, 2025·1 cites·29 claims
- 0485US2025223593A1Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2024·Application pending·0 cites
- 0582US12275937B2Stereospecific linkages in RNA editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2019·Granted Apr 15, 2025·2 cites·14 claims
- 0668US2024229030A9Nucleic acid molecules for pseudouridylationUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 0763US2025304962A1Stereospecific linkages in rna editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2025·Application pending·0 cites
- 0862US11866702B2Nucleic acid molecules for pseudouridylationUNIV ROCHESTER·Filed 2019·Granted Jan 9, 2024·0 cites·24 claims
- 0951US2022127609A1Antisense oligonucleotides for nucleic acid editingPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 1046US2021079393A1Antisense oligonucleotides for rna editingPROQR THERAPEUTICS II BV·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julien Auguste Germain Boudet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →